Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain - PubMed (original) (raw)
Review
doi: 10.1093/jac/dkq415. Epub 2010 Nov 16.
Affiliations
- PMID: 21081548
- DOI: 10.1093/jac/dkq415
Review
Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
Benjamin A Rogers et al. J Antimicrob Chemother. 2011 Jan.
Abstract
Escherichia coli sequence type 131 (ST131) is a worldwide pandemic clone, causing predominantly community-onset antimicrobial-resistant infection. Its pandemic spread was identified in 2008 by utilizing multilocus sequence typing (MLST) of CTX-M-15 extended-spectrum β-lactamase-producing E. coli from three continents. Subsequent research has confirmed the worldwide prevalence of ST131 harbouring a broad range of virulence and resistance genes on a transferable plasmid. A high prevalence of the clone (∼30%-60%) has been identified amongst fluoroquinolone-resistant E. coli. In addition, it potentially harbours a variety of β-lactamase genes; most often, these include CTX-M family β-lactamases, and, less frequently, TEM, SHV and CMY β-lactamases. Our knowledge of ST131's geographical distribution is incomplete. A broad distribution has been demonstrated amongst antimicrobial-resistant E. coli from human infection in Europe (particularly the UK), North America, Canada, Japan and Korea. High rates are suggested from limited data in Asia, the Middle East and Africa. The clone has also been detected in companion animals, non-companion animals and foods. The clinical spectrum of disease described is similar to that for other E. coli, with urinary tract infection predominant. This can range from cystitis to life-threatening sepsis. Infection occurs in humans of all ages. Therapy must be tailored to the antimicrobial resistance phenotype of the infecting isolate and the site of infection. Phenotypic detection of the ST131 clone is not possible and DNA-based techniques, including MLST and PCR, are described.
Similar articles
- Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, López C, Cortés P, Llagostera M, Leflon-Guibout V, Puentes B, Mamani R, Herrera A, Coira MA, García-Garrote F, Pita JM, Blanco J. Blanco M, et al. J Antimicrob Chemother. 2009 Jun;63(6):1135-41. doi: 10.1093/jac/dkp122. Epub 2009 Apr 7. J Antimicrob Chemother. 2009. PMID: 19351692 - Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP. Yumuk Z, et al. J Antimicrob Chemother. 2008 Aug;62(2):284-8. doi: 10.1093/jac/dkn181. Epub 2008 May 2. J Antimicrob Chemother. 2008. PMID: 18453527 - Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
Peirano G, Costello M, Pitout JD. Peirano G, et al. Int J Antimicrob Agents. 2010 Jul;36(1):19-23. doi: 10.1016/j.ijantimicag.2010.02.016. Epub 2010 Mar 31. Int J Antimicrob Agents. 2010. PMID: 20359869 - Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4.
Peirano G, Pitout JD. Peirano G, et al. Int J Antimicrob Agents. 2010 Apr;35(4):316-21. doi: 10.1016/j.ijantimicag.2009.11.003. Epub 2010 Jan 13. Int J Antimicrob Agents. 2010. PMID: 20060273 Review. - Addressing the challenge of extended-spectrum beta-lactamases.
Zahar JR, Lortholary O, Martin C, Potel G, Plesiat P, Nordmann P. Zahar JR, et al. Curr Opin Investig Drugs. 2009 Feb;10(2):172-80. Curr Opin Investig Drugs. 2009. PMID: 19197795 Review.
Cited by
- Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131.
Birgy A, Mariani-Kurkdjian P, Bidet P, Doit C, Genel N, Courroux C, Arlet G, Bingen E. Birgy A, et al. J Clin Microbiol. 2013 Jun;51(6):1727-32. doi: 10.1128/JCM.03255-12. Epub 2013 Mar 20. J Clin Microbiol. 2013. PMID: 23515552 Free PMC article. - Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131.
Kim YA, Qureshi ZA, Adams-Haduch JM, Park YS, Shutt KA, Doi Y. Kim YA, et al. Clin Infect Dis. 2012 Jul;55(2):224-31. doi: 10.1093/cid/cis387. Epub 2012 Apr 4. Clin Infect Dis. 2012. PMID: 22491340 Free PMC article. - Insight into neonatal septicaemic Escherichia coli from India with respect to phylogroups, serotypes, virulence, extended-spectrum-β-lactamases and association of ST131 clonal group.
Roy S, Datta S, DAS P, Gaind R, Pal T, Tapader R, Mukherjee S, Basu S. Roy S, et al. Epidemiol Infect. 2015 Nov;143(15):3266-76. doi: 10.1017/S0950268815000539. Epub 2015 Apr 10. Epidemiol Infect. 2015. PMID: 25858453 Free PMC article. - Verona integron-encoded metallo-β-lactamase 1 in Enterobacteria, Ontario, Canada.
Tijet N, Macmullin G, Lastovetska O, Vermeiren C, Wenzel P, Stacey-Works T, Low DE, Patel SN, Melano RG. Tijet N, et al. Emerg Infect Dis. 2013 Jul;19(7):1156-8. doi: 10.3201/eid1907.121294. Emerg Infect Dis. 2013. PMID: 23763841 Free PMC article. No abstract available. - Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes.
Brisse S, Diancourt L, Laouénan C, Vigan M, Caro V, Arlet G, Drieux L, Leflon-Guibout V, Mentré F, Jarlier V, Nicolas-Chanoine MH; Coli β Study Group. Brisse S, et al. J Clin Microbiol. 2012 Sep;50(9):2974-81. doi: 10.1128/JCM.00919-12. Epub 2012 Jul 3. J Clin Microbiol. 2012. PMID: 22760036 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical